13023_2019_1195_MOESM3_ESM.docx (40.07 kB)
MOESM3 of Effects of recombinant human growth hormone treatment on growth, body composition, and safety in infants or toddlers with Prader-Willi syndrome: a randomized, active-controlled trial
journal contribution
posted on 2019-09-12, 04:11 authored by Aram Yang, Jin-Ho Choi, Young Sohn, Yunae Eom, Jiyoon Lee, Han-Wook Yoo, Dong-Kyu JinAdditional file 3: Table S3. Analysis of covariance on the change from baseline of LBM (g) at week 52 (Efficacy set).